Skip to main content

Site notifications

Notice for treosulfan (Link Medical Products Pty Ltd)

Active ingredients
treosulfan
Date of review outcome
Lapse date
Type
Orphan drug
Indication
Treosulfan is indicated for the conditioning treatment prior to haematopoietic stem cell transplantion
Therapeutic area
Haematology

Help us improve the Therapeutic Goods Administration site